Evaluation of TLQP-21 in relation to oxidative stress biomarkers in obesity
DOI:
https://doi.org/10.53704/Keywords:
TLQP-21, Obesity, Oxidative stress, Malondialdehyde, Antioxidant, IraqAbstract
This study investigated serum TLQP-21, a VGF-derived peptide involved in energy balance, in human obesity and its relationship with oxidative stress. One hundred obese adults and 50 non-obese controls from Mosul, Northern Iraq, were compared. Serum TLQP-21 was measured by ELISA, alongside malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT). Obese participants had significantly higher TLQP-21 (p = 4.41 × 10⁻³³) and MDA (p = 1.38 × 10⁻³⁷), and lower GSH (p = 2.87 × 10⁻⁴²), SOD (p = 5.10 × 10⁻²⁰), and CAT (p = 1.13 × 10⁻¹⁸) than controls; all differences remained significant after Bonferroni correction. TLQP-21 correlated positively with BMI and MDA and inversely with GSH, SOD, and CAT. In regression modelling, BMI, MDA, and GSH were associated with TLQP-21. The internally derived ROC area was 0.94. The authors conclude that serum TLQP-21 correlates with oxidative stress parameters in obesity, but the cross-sectional design and lack of external validation of the ROC cutoff preclude establishing causality or clinical diagnostic use at present.
References
1. Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017;11(8):215-25. doi:10.1177/1753944717711379
2. Nimptsch K, Konigorski S, Pischon T. Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine. Metabolism. 2019;92:61-70. doi:10.1016/j.metabol.2018.12.006
3. Bartolomucci A, La Corte G, Possenti R, Locatelli V, Rigamonti AE, Torsello A, et al. TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity. Proc Natl Acad Sci U S A. 2006;103(39):14584-9. doi:10.1073/pnas.0606102103
4. Cero C, Razzoli M, Han R, Sahu BS, Patricelli J, Guo ZK, et al. The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis. Mol Metab. 2017;6(1):148-58. doi:10.1016/j.molmet.2016.10.005
5. Sahu BS, Rodriguez P, Nguyen ME, Han R, Cero C, Razzoli M, et al. Peptide/receptor co-evolution explains the lipolytic function of the neuropeptide TLQP-21. Cell Rep. 2019;28:2567-80. doi:10.1016/j.celrep.2019.07.101
6. Alkhalidy LS. A clinical study of vitamin D and its association with obesity. In: International Middle Eastern Simulation and Modelling Conference (MESM 2024); 2025. p. 57-61.
7. Allwsh TA, Abdulla LS. Association of osteocalcin with some antioxidant parameters in diabetes mellitus in Iraq. J Org Inorg Chem. 2018;4. doi:10.21767/2472-1123-C3-009
8. Gart E, Snabel J, de Jong JCBC, Verschuren L, Van den Hoek AM, Morrison MC, et al. Biomarkers of metabolism and inflammation in individuals with obesity and normal weight: a comparative analysis exploring sex differences. Int J Mol Sci. 2025;26(15):7576. doi:10.3390/ijms26157576
9. Cassina V, Torsello A, Tempestini A, Salerno D, Brogioli D, Tamiazzo L, et al. Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity. Biochim Biophys Acta. 2013;1828:455-60. doi:10.1016/j.bbamem.2012.10.023
10. Gedam M, Zheng H. Complement C3aR signaling: immune and metabolic modulation and its impact on Alzheimer's disease. Eur J Immunol. 2024;54(8):2350815. doi:10.1002/eji.202350815
11. Dalbøge LS, Jacobsen JM, Mehrotra S, Mercer AJ, Cox N, Liu F, et al. Evaluation of VGF peptides as potential anti-obesity candidates in pre-clinical animal models. Peptides. 2021;136:170444. doi:10.1016/j.peptides.2020.170444
12. Medeiros PRO, Del Duca GF, Streb AR, Heberle I, Leonel LS, Gerage AM. Anthropometric indicators associated with blood pressure elevation in adults with obesity. Acta Sci Health Sci. 2020;42(1):e50918. doi:10.4025/actascihealthsci.v42i1.50918
13. Galland F, de Espindola JS, Lopes DS, Taccola MF, Pacheco MTB. Food-derived bioactive peptides: mechanisms of action underlying inflammation and oxidative stress in the central nervous system. Food Chem Adv. 2022;1:100087.
14. Possenti R, Muccioli G, Petrocchi P, Cero C, Cabassi A, Vulchanova L, et al. Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21. Biochem J. 2012;441(1):511-22. doi:10.1042/BJ20111165
15. Li XX, Lee JD, Lee HS, Clark RJ, Woodruff TM. TLQP-21 is a low potency partial C3aR activator on human primary macrophages. Front Immunol. 2023;14:1086673. doi:10.3389/fimmu.2023.1086673
16. ?olak E, Pap D. The role of oxidative stress in the development of obesity and obesity-related metabolic disorders. J Med Biochem. 2021;40(1):1-9. doi:10.5937/jomb0-24652
17. Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021;320(3):C375-91. doi:10.1152/ajpcell.00379.2020
18. Sahu BS, Nguyen ME, Rodriguez P, Pallais JP, Ghosh V, Razzoli M, et al. The molecular identity of the TLQP-21 peptide receptor. Cell Mol Life Sci. 2021;78(23):7133-44. doi:10.1007/s00018-021-03944-1
19. Gambini J, Stromsnes K. Oxidative stress and inflammation: from mechanisms to therapeutic approaches. Biomedicines. 2022;10:753. doi:10.3390/biomedicines10040753
20. Nadya GA, Jafer AK, Mahmood WT, Alkabban M. Evaluation of insulin resistance according to obesity grades in Iraqi non-diabetic adults. Biochem Cell Arch. 2020;20(1):2157-62. doi:10.35124/bca.2020.20.1.2157
21. Sahu BS, Razzoli M, McGonigle S, Pallais JP, Nguyen ME, Sadahiro M, et al. Targeted and selective knockout of the TLQP-21 neuropeptide unmasks its unique role in energy homeostasis. Mol Metab. 2023;76:101781. doi:10.1016/j.molmet.2023.101781
22. Taki AG, Mohammed SA, Allwsh TA. Asprosin: relation to oxidative stress for metabolic syndrome patients in Mosul/Iraq. Periódico Tchê Quím. 2024;21(48). doi:10.52571/PTQ.v21.n48.2024_11_TAKI_pgs_132_139
23. Li H, Ren J, Li Y, Wu Q, Wei J. Oxidative stress: the nexus of obesity and cognitive dysfunction in diabetes. Front Endocrinol. 2023;14:1134025.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 ali saadi, Liqaa Saeed Alkhalidy, Thikra Ali Allwsh, Abeer Mansour Abdel Rasool

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright of their work, with first publication rights granted to Fountain Journal of Natural and Applied Sciences. Articles in FUJNAS are published on the Creative Commons Attribution 4.0 International license (CC BY 4.0).
